Xinjiang Wang, PhD

Associate Professor
Department of Pharmacology and Therapeutics
Member, Molecular Pharmacology and Cancer Therapeutics Graduate Program
Member, Experimental Therapeutics CCSG (Comprehensive Cancer Support Grant) Program
Roswell Park Comprehensive Cancer Center
Special Interests: 
Molecular regulation of the tumor suppressor p53 pathway
Molecular regulation of the tumor suppressor PTEN/AKT pathway
Identification of cancer E3 ligases
High throughput screening of therapeutic inhibitors targeting oncogenic E3 ligases
Development of mechanism-based targeted combination cancer therapies


Education and Training: 
Post-doctoral - Memorial Sloan-Kettering Cancer Center, New York, NY
PhD - Weizmann Institute of Science, Rehovot, Israel
Professional Memberships: 
American Association for Cancer Research
American Society of Biochemistry and Molecular Biology (ASBMB)